Sponsor Oversight Assessment
2-4 weeks
A focused review of governance, vendor interfaces, risk, issues, and the most important corrective actions.
Choose a focused diagnostic, embedded sponsor-side leadership, or a time-bound rescue engagement. 4Cs works inside the existing sponsor and CRO model, with defined deliverables, interfaces, boundaries, and response expectations.
Engagements can be fixed-scope, monthly, quarterly, project-based, or training-based. Final pricing depends on complexity, coverage, geography, urgency, and deliverables.
2-4 weeks
A focused review of governance, vendor interfaces, risk, issues, and the most important corrective actions.
Monthly or quarterly
Defined-capacity leadership integrated with the sponsor, CRO, and vendor operating cadence.
Fixed scope or embedded
Medical-review pathways, safety interfaces, response expectations, and traceable follow-up.
4-12 weeks
A time-bound intervention for delayed studies, leadership transition, audit, inspection, or database-lock risk.
Phased fixed scope
Saudi Arabia or Egypt feasibility, partner interfaces, startup dependencies, and sponsor governance.
Embedded sponsor-side operational leadership to drive oversight, decision traceability, and execution discipline alongside CRO and vendor teams.
Response expectations are defined at project initiation, aligned to protocol risk and enrollment pace.
Sponsor clinical operations, CRO study team, vendors, functional leads.
Does not replace sponsor-of-record responsibilities and does not act as a full CRO.
Structured medical review and safety governance, including escalation pathways, cadence, and traceable outcomes.
Standard targets often include 24 to 48 hour medical escalation response where applicable. Final SLAs are contractual.
Sponsor medical lead, PV, CRO medical monitor, safety vendor, sites through defined pathways.
Not a 24/7 call center unless contracted and documented.
Support vendor performance tracking, escalation discipline, and documented governance.
Escalations are time stamped and closed with documented outcomes.
Sponsor vendor management, CRO PM, quality, functional vendors.
Does not contract as the prime CRO unless explicitly engaged under separate terms.
Readiness support designed to keep oversight, documentation, and processes inspection ready throughout execution.
Cadence and scope are aligned to study phase, geography, and inspection risk profile.
Sponsor QA, CRO TMF, clinical ops, functional owners.
Controlled documents are provided during qualification, not published publicly.
Role-based training connected to GCP principles, sponsor oversight, clinical operations, escalation, documentation, and research-center readiness.
Programs are scoped to the audience, operating model, language, and delivery format.
Sponsor functions, CRO teams, hospitals, research centers, and clinical research staff.
Does not replace institution-specific qualification requirements or confer professional licensure.
Operational enablement for expansion, with partner alignment, feasibility, and continuity planning for time zone coverage.
Response commitments defined per engagement.
Sponsor operations, CRO, local partners as applicable.
Sponsors and CROs retain regulatory responsibilities as defined by contract.
Senior oversight capacity around outsourced clinical programs.
View support modelSponsor-facing governance, medical, recovery, and regional support.
View support modelResearch readiness, SOP, training, and sponsor-facing operating foundations.
View support modelSaudi Arabia and Egypt planning, interfaces, governance, and startup risk.
View support model